Joost Peerbooms

33 Concentrations of blood components in PRP separation systems 53. Sommeling C, Heyneman A, Hoeksema H, et al. The use of platelet-rich plasma in plastic surgery: a systematic review. J Plast Reconstr Aesthet Surg. 2013; 66(3): 301-11. 54. Sundman E, Cole B, Fortier L. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med. 2011; 39(10):2135-40. 55. Weibrich G, Kleis W, Hafner G, et al. Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bank. Clin Oral Implants Res. 2003; 14: 357-62. 56. Weibrich G, Kleis W, Hitzler W, et al. Comparison of the platelet concentrate collection system with the plasma-rich-in-growth-factors kit to produce platelet-rich plasma: a technical report. Int J Oral Maxillofac Implants. 2005; 20(1): 118-23. 57. Weibrich G, Kleis W, Streckbein P, et al. Comparison of point-of-care methods for preparation of platelet concentrate (platelet-rich plasma). Int J Oral Maxillofac Implants. 2012; 27(4): 762-69. 58. Willits K, Kaniki N, Bryant D. The use of platelet-rich plasma in orthopaedic injuries. Sports Med Arthrosc. 2013; 21(4): 225-30. 59. Yin W, Qi X, Zhang Y, et al. Advantages of pure platelet-rich plasma compared with leukocyte- and platelet-rich plasma in promoting repair of bone defects. J Transl Med. 2016; 14: 73. 60. Yin W, Xu H, Sheng J, et al. Advantages of pure platelet-rich plasma compared with leukocyte- and platelet-rich plasma in treating rabbit knee osteoarthritis. Med Sci Monit. 2016; 22: 1280-90. 61. Zhang L, Chen S, Chang P, et al. Harmful effects of leukocyte-rich platelet-rich plasma on rabbit tendon stem cells in vitro. Am J Sports Med. 2016; 44(8): 1941-51. 62. Zhou Y, Zhang J, Wu H, et al. The differential effects of leukocyte-containing and pure platelet-rich plasma (PRP) on tendon stem/progenitor cells: implications of PRP application for the clinical treatment of tendon injuries. Stem Cell Res Ther. 2015; 6: 173. 63. Zimmermann R, Arnold D, Strasser E, et al. Sample preparation technique and white cell content influence the detectable levels of growth factors in platelet concentrates. VoxSang. 2003; 85: 283-89. 64. Zimmermann R, Jakubietz R, Jakubietz M, et al. Different preparation methods to obtain platelet components as a source of growth factors for local application. Transfusion. 2001; 41(10): 1217-24. 2